Cargando…
First report of multi-drug resistant tuberculosis in a systemic lupus erythematosus patient
BACKGROUND: Treatment of a multi-drug resistant tuberculosis (MDR-TB) patient is clinically challenging, requiring a minimum of 18 months of therapy. Its occurrence in a systemic lupus erythromatosus (SLE) patient may complicate management of both MDR-TB and SLE. This is the first descriptive report...
Autores principales: | Dorjee, Kunchok, Dierberg, Kerry L, Sadutshang, Tsetan D, Reingold, Arthur L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527098/ https://www.ncbi.nlm.nih.gov/pubmed/26245637 http://dx.doi.org/10.1186/s13104-015-1302-x |
Ejemplares similares
-
Improved Detection of Tuberculosis and Multidrug-Resistant Tuberculosis among Tibetan Refugees, India
por: Dierberg, Kerry L., et al.
Publicado: (2016) -
Risk of developing active tuberculosis following tuberculosis screening and preventive therapy for Tibetan refugee children and adolescents in India: An impact assessment
por: Dorjee, Kunchok, et al.
Publicado: (2021) -
First case of extensively drug-resistant tuberculosis treated with both delamanid and bedaquiline
por: Tadolini, Marina, et al.
Publicado: (2016) -
Risk of cardiovascular events from current, recent, and cumulative exposure to abacavir among persons living with HIV who were receiving antiretroviral therapy in the United States: a cohort study
por: Dorjee, Kunchok, et al.
Publicado: (2017) -
Acute myocardial infarction associated with abacavir and tenofovir based antiretroviral drug combinations in the United States
por: Dorjee, Kunchok, et al.
Publicado: (2021)